Clinical trial

A Double-blinded, Randomised, Four-period Crossover Euglycemic Clamp Trial Investigating the Dose-response and Dose-exposure Relationship of BioChaperone Insulin Lispro in Three Different Doses in Subjects With Type 1 Diabetes

NCT02146651

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2014-05-01

PhasePHASE2

Study timeline

Study start (unknown)2014-05-01Date precision: month

Registry last updated2014-12-10

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Diabetes Mellitus Type 1unresolved

Interventions

BioChaperone insulin lispro 0.2U/KgDRUG

BioChaperone insulin lispro 0.1U/KgDRUG

BioChaperone insulin lispro 0.4U/KgDRUG

Humalog®DRUG

Sponsors & collaborators

Adocialead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT02146651 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.